Knight Therapeutics's market cap is currently C$595.56M. The company's EPS TTM is C$-0.04; its P/E ratio is -169.01; Knight Therapeutics is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is Cgt;-0.01. See an overview of income statement, balance sheet, and cash flow financials.
